Since the introduction of Edward Jenner's smallpox vaccine in 1796, vaccines have proven invaluable for their ability to stimulate the immune system and to confer protection against pathogenic organisms. Progress in modern vaccine research has been accompanied by a dramatic increase in the number of vaccine-related papers in the published literature. It has become increasingly challenging to identify and annotate vaccine data from this large and diverse literature which no one scientist or team can fully master. Although vaccine databases exist that emphasize commercialized vaccines, no public central repository is available to store research data concerning commercial vaccines, vaccines in clinical trials, or vaccine candidates in early stages of development, in a fashion that render such data available for advanced analyses. To fill this need, we have developed VIOLIN (www.violinet.org), a web-based database system for annotation, storage, and analysis of published vaccine data. An ontology represents consensus-based controlled vocabularies of terms and relations, with associated definitions which are logically formulated in such a way as to promote automated reasoning. A bottleneck of vaccine research and further VIOLIN development is the lack of a vaccine ontology, which in turn makes a significant obstacle for vaccine data standardization, retrieval, integration, and advanced analysis and prediction. Our goal is to develop the community-based Vaccine Ontology (VO) and apply it to efficient vaccine literature mining and analysis of protective immune mechanisms. We will focus on two model pathogens: Escherichia coli and Brucella species. This project contains three specific aims: (1) develop a community-based Vaccine Ontology (VO), and apply it to establish a vaccine knowledgebase and to promote vaccine data integration and query through Semantic Web. The VO development will be achieved through collaboration with vaccine researchers, the Infectious Disease Ontology (IDO) Initiative, and the National Center for Biomedical Ontology (NCBO);(2) develop a VO-based natural language processing (NLP) system and apply it for more efficient retrieval of Brucella and E. coli vaccine information, automated annotation of journal articles with VO terms, and VO improvement. This task will be achieved by collaboration with the National Center for Integrative Biomedical Informatics (NCIBI). (3) analyze and predict vaccine targets and protective immune networks attributable to the interactions between host and vaccine. This will be achieved mainly by VO-based literature mining and a novel genome- and literature-based statistical methodology. This project will be implemented by a strong collaborative team and supported from a large user community. The Vaccine Ontology and its applications to literature mining and for studying protective immunity against Brucella spp. and E. coli will lay a strong foundation for further advanced informatics research on vaccines against infectious diseases in the post-genomics and information era.

Public Health Relevance

Vaccines stimulate the immune system and confer protection against pathogenic microorganisms. A bottleneck of vaccine research is the lack of an ontology (consensus- based controlled vocabularies of terms and relations) to ensure consistency of literature curation and support automated reasoning. The goal of this project is to develop a community-based Vaccine Ontology and apply it to vaccine literature mining and analysis of vaccine-induced immune mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI081062-03
Application #
8120230
Study Section
Biodata Management and Analysis Study Section (BDMA)
Program Officer
Gezmu, Misrak
Project Start
2009-09-22
Project End
2013-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
3
Fiscal Year
2011
Total Cost
$264,994
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Veterinary Sciences
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ong, Edison; Wong, Mei U; He, Yongqun (2017) Identification of New Features from Known Bacterial Protective Vaccine Antigens Enhances Rational Vaccine Design. Front Immunol 8:1382
Wang, Liwei; Li, Mei; Xie, Jiangan et al. (2017) Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China. Sci Rep 7:13819
Ni, Zhaohui; Chen, Yan; Ong, Edison et al. (2017) Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology. Int J Mol Sci 18:
Sarntivijai, Sirarat; Zhang, Shelley; Jagannathan, Desikan G et al. (2016) Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors. Drug Saf 39:697-707
Guo, Abra; Racz, Rebecca; Hur, Junguk et al. (2016) Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events. J Biomed Semantics 7:29
He, Yongqun (2016) Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research. Curr Pharmacol Rep 2:113-128
Bandrowski, Anita; Brinkman, Ryan; Brochhausen, Mathias et al. (2016) The Ontology for Biomedical Investigations. PLoS One 11:e0154556
Todd, Thomas; Dunn, Natalie; Xiang, Zuoshuang et al. (2016) Vaxar: A Web-Based Database of Laboratory Animal Responses to Vaccinations and Its Application in the Meta-Analysis of Different Animal Responses to Tuberculosis Vaccinations. Comp Med 66:119-28
He, Yongqun; Ong, Edison; Xie, Jiangan (2016) Integrative representations and analyses of vaccine-induced intended protective immunity and unintended adverse events using ontology-based and theory-guided approaches. Glob Vaccines Immunol 1:37-39
Xie, Jiangan; Zhao, Lili; Zhou, Shangbo et al. (2016) Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases. Sci Rep 6:34318

Showing the most recent 10 out of 35 publications